A potent hypotensive peptide, novokinin, induces relaxation by AT 2- and IP-receptor-dependent mechanism in the mesenteric artery from SHRs

Bioscience, Biotechnology and Biochemistry

Volumn 72, Issue 1, 2008, Pages 257-259

  Yamada, Yuko ^a   Yamauchi, Daiki ^a   Yokoo, Megumi ^a   Ohinata, Kousaku ^a   Usui, Hachiro ^a   Yoshikawa, Masaaki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

AT2 receptor; IP receptor; Novokinin; Spontaneously hypertensive rat (SHR); Vasorelaxation

Indexed keywords

AT2 RECEPTOR; IP RECEPTOR; NOVOKININ; SPONTANEOUSLY HYPERTENSIVE RAT (SHR); VASORELAXATION;

BLOOD VESSELS; ENZYME INHIBITION; ESTERS; RATS;

PEPTIDES;

ANTIHYPERTENSIVE AGENT; ARG PRO LEU LYS PRO TRP; ARG-PRO-LEU-LYS-PRO-TRP; N(G) NITROARGININE METHYL ESTER; OLIGOPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; DRUG EFFECT; MESENTERIC ARTERY; PHYSIOLOGY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASODILATATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; MESENTERIC ARTERIES; NG-NITROARGININE METHYL ESTER; OLIGOPEPTIDES; RATS; RATS, INBRED SHR; VASODILATION;

RATTUS;

EID: 38549130676     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.70638     Document Type: Article

References (12)

1. Matoba, N., Usui, H., Fujita, H., and Yoshikawa, M., A novel anti-hypertensive peptide derived from ovalbumin induces nitric oxide-mediated vasorelaxation in an isolated SHR mesenteric artery. FEBS Lett., 452, 181-184 (1999).
2. Yamada, Y., Matoba, N., Usui, H., Ohnishi, K., and Yoshikawa, M., Design of a highly potent anti-hypertensive peptide based on ovokinin(2-7). Biosci. Biotechnol. Biochem., 66, 1213-1217 (2002).
3. Widdop, R. E., Gardiner, S. M., Kemp, P. A., and Bennett, T., Differential blockade of central effects of angiotensin II by AT2-receptor antagonists. Am. J. Physiol., 265, H226-H231 (1993).
4. 2 receptor and prostaglandin IP receptor. Peptides, in press.
5. Siragy, H. M., and Carey, R. M., The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J. Clin. Invest., 100, 264-269 (1997).
6. Tsutsumi, Y., Matsubara, H., Masaki, H., Kurihara, H., Murasawa, S., Takai, S., Miyazaki, M., Nozawa, Y., Ozono, R., Nakagawa, K., Miwa, T., Kawada, N., Mori, Y., Shibasaki, Y., Tanaka, Y., Fujiyama, S., Koyama, Y., Fujiyama, A., Takahashi, H., and Iwasaka, T., Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J. Clin. Invest., 104, 925-935 (1999).
7. Carey, R. M., Wang, Z. Q., and Siragy, H. M., Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function. Hypertension, 35, 155-163 (2000).
8. Carey, R. M., Jin, X., Wang, Z., and Siragy, H. M., Nitric oxide: a physiological mediator of the type 2 (AT2) angiotensin receptor. Acta Physiol. Scand., 168, 65-71 (2000).
9. Baranov, D., and Armstead, W. M., Nitric oxide contributes to AT2 but not AT1 angiotensin II receptor-mediated vasodilatation of porcine pial arteries and arterioles. Eur. J. Pharmacol., 525, 112-116 (2005).
10. Savoia, C., Ebrahimian, T., He, Y., Gratton, J. P., Schiffrin, E. L., and Touyz, R. M., Angiotensin II/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase. J. Hypertens., 24, 2417-2422 (2006).
11. Clark, R. D., Jahangir, A., Severance, D., Salazar, R., Chang, T., Chang, D., Jett, M. F., Smith, S., and Bley, K., Discovery and SAR development of 2-(phenylamino) imidazolines as prostacyclin receptor antagonists. Bioorg. Med. Chem. Lett., 14, 1053-1056 (2004).
12. Frölich, J. C., Prostacyclin in hypertension. J. Hypertens. Suppl., 8, S73-78 (1990).